decided something had to be done.

Thus was Morrison - who has worked on NASA's Voyager, Galileo and Kepler missions in his decadeslong career - forced to make YouTube videos for frightened children.

"I got a note from a 12-year-old girl. She said she and her classmates were scared," he said in a 2011 video. "The simplest thing to say is there is no evidence whatsoever from the existence of Nibiru."

Sure enough, no phantom star disrupted Earth's orbit in 2012.

Sure enough, the fear of it continued to disrupt Morrison's work up to the present day.

As Kristine Phillips wrote for The Washington Post, a conspiracy theorist put a biblical spin on the Nibiru theory this year, claiming to have deduced from the Book of Revelation that it would set off ato dramatically impact HCV-related disease burden globally. Indeed, new HCV treatments have been deemed so important that some (sofosbuvir, daclatasvir) were added to the 2015 WHO Essential Medicines List along with a number of their combinations [@jve3-bib-0022]. However, access to these essential medications is limited by their exceptionally high pricing, up to USD93,000 per 12-week course. In turn this has limited broad implementation in many countries, with restrictions based on liver disease stage generally introduced to reduce budget impact [@jve3-bib-0023].

Australia was late to list the DAAs onto the Pharmaceutical Benefits Scheme (PBS). Prior to the commencement of the Australian government-funded HCV treatment program in March 2016, an estimated 1400 Australian patients had been treated with the assistance of FixHepC, a web-based platform for the importation of HCV therapies